Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort-Reference-Cited by-同舟云学术

Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort

Published:2022-03 Issue:2 Volume:16 Page:198-207
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Silva Pãmela Rodrigues de S.^ORCID,Jannes Cinthia E.,Oliveira Theo G.M.,Krieger José E.,Santos Raul D.^ORCID,Pereira Alexandre C.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Familial hypercholesterolemia;Bouhairie;Cardiol Clin,2015

2. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia;Silva;Atherosclerosis,2016

3. Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study;Mangili;Atherosclerosis,2017

4. Familial hypercholesterolemia treatments: Guidelines and new therapies;Raal;Atherosclerosis,2018

5. Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects;Beheshti;J Am Coll Cardiol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability;Pharmacogenetics and Genomics;2024-02-07